NCT04184193

Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)

Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM) - a Retrospective Analysis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 58 (actual)
• Sponsor: Schön Klinik Berchtesgadener Land · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Data from patients with the orphan disease of lymphangioleiomyomatosis (LAM) which performed a pulmonary Rehabilitation program will be analyzed retrospectively. Data will be taken from the internal data base of the reference Center (Schoen Klinik Berchtesgadener Land, Schoenau, Germany) where These data were collected during clinical routine. Data will be included from the year 2000 until now. A retrospectively matched COPD cohort will be included for comparison.

Conditions

• Lymphangioleiomyomatosis
• LAM
• Pulmonary Rehabilitation

Interventions

Type	Name	Description
OTHER	Pulmonary Rehabilitation	Patients will perform a comprehensive, inpatient pulmonary rehabilitation program for 4 weeks duration

Timeline

• Start date: 2019-12-03
• Primary completion: 2019-12-23
• Completion: 2019-12-23
• First posted: 2019-12-03
• Last updated: 2020-01-21

Locations

1 site across 1 country: Germany